chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine received on 08/10/21.  Peripheral Neuropathy in legs began on 08/14/21.  Leg neuropathy continues and is really a struggle to walk.  Headaches began around 08/10/21 and remain a daily occurance.  Vision challenges began over the last week or so.
Herpes and Shingles outbreak simultaneously. Herpes sores on outside of mouth L side and Shingles outbreak on back of L calf.
Patient felt dizzy and had to lay down on floor. After 10 minutes, patient felt better to sit upright on chair.  Fire department came to check on patient and provided care, but patient declined to go to hospital.  Followed up with patient at 2:30pm and spoke to husband who stated she is doing much better and feels fatigued and sleeping it off. Patient stated she didn't eat anything except a quick snack in car prior to appointment.
This is a spontaneous report from a contactable physician (reporting for daughter) from a Pfizer-sponsored program 2017 Trumenba non-operationalized research. An  18-year-old female patient of an unspecified ethnicity received first dose of TRUMENBA via an unspecified route of administration, on 06Jan2017, single dose for immunization. Relevant medical history and concomitant medications were not reported. After the first dose of meningococcal group B vaccine on 06Jan2017, the patient experienced redness (10 cm), swelling, pain, malaise, headache, nausea, dizziness, fever to 102 degree F, muscle and joint ache, and diarrhea. Outcome of the events was unknown. The information on the batch number has been requested.
Runny nose, Cough, Rapid breathing, high fever, lethargic, diagnosed with Pnuemonia, started antibiotic treatment, still in progress.
nauseous; sick; This is a spontaneous report from a contactable consumer or other non health care professional (Patient). A female patient of an unspecified age received bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient wanted to call and report her reaction to the Pfizer Biontech Covid 19 vaccine. The patient reported that she had a little bit of reaction to the first shot, she was nauseous and sick on an unspecified date. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
8 year old received 0.5ml dose of the Moderna covid19 vaccine; it was expired/ received expired vaccine; received first dose of Pfizer and second dose of Moderna; it was left out of the refrigerator since Friday the 25Feb2022; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (8 year old received 0.5ml dose of the Moderna covid19 vaccine), EXPIRED PRODUCT ADMINISTERED (it was expired/ received expired vaccine), PRODUCT STORAGE ERROR (it was left out of the refrigerator since Friday the 25Feb2022) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received first dose of Pfizer and second dose of Moderna) in an 8-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer vaccine (first dose) on 25-Jan-2022. Past adverse reactions to the above products included No adverse event with Pfizer vaccine.    On 28-Feb-2022, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 25-Feb-2022, the patient experienced PRODUCT STORAGE ERROR (it was left out of the refrigerator since Friday the 25Feb2022). On 28-Feb-2022, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (8 year old received 0.5ml dose of the Moderna covid19 vaccine), EXPIRED PRODUCT ADMINISTERED (it was expired/ received expired vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received first dose of Pfizer and second dose of Moderna). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (8 year old received 0.5ml dose of the Moderna covid19 vaccine), EXPIRED PRODUCT ADMINISTERED (it was expired/ received expired vaccine), PRODUCT STORAGE ERROR (it was left out of the refrigerator since Friday the 25Feb2022) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received first dose of Pfizer and second dose of Moderna) outcome was unknown.            There was no medical history at the time of vaccination. No concomitant medication information was provided.  The patient received 0.5ml vaccine dose of the Moderna covid19 vaccine as his second dose and that it was expired because it was left out of the refrigerator since Friday the 25-Feb-2022. The first dose was of Pfizer which was taken on 28-Feb-2022. Patient's allergies (medications, food and other products) related information was unknown. It was unknown if the patient ever had COVID  test or diagnosis.  The AE did not cause patient to seek medical care (office visit, Urgent care, ER, hospitalized). It was unknown if the patient experienced a similar event in the past. The patient had no symptoms.  No treatment medication information was provided.   Reporter did not allow further contact
This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (got sick), MALAISE (symptoms similar to covid), LETHARGY (lethargic), DECREASED APPETITE (no appetite) and DIARRHEA (diarrhea) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 on 13-Nov-2020 and COVID-19 on 02-Apr-2021. Concurrent medical conditions included Food allergy (Red Dye). Concomitant products included IBUPROFEN for an unknown indication. On 29-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-May-2021, the patient experienced PYREXIA (fever of 102 for 2 days). On an unknown date, the patient experienced ILLNESS (got sick), MALAISE (symptoms similar to covid), LETHARGY (lethargic), DECREASED APPETITE (no appetite), DIARRHOEA (diarrhea), CHILLS (chills), FATIGUE (tired) and NAUSEA (nauseous). On 31-May-2021, PYREXIA (fever of 102 for 2 days) had resolved. At the time of the report, ILLNESS (got sick), MALAISE (symptoms similar to covid), LETHARGY (lethargic), DECREASED APPETITE (no appetite), DIARRHOEA (diarrhea), CHILLS (chills), FATIGUE (tired) and NAUSEA (nauseous) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-May-2021, Body temperature: 102 (High) Fever. On 29-May-2021, SARS-CoV-2 antibody test: positive (Positive) Had been diagnosed with COVID twice. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Reporter information, Symptoms similar to COVID, 102 degree fever were updated. On 29-Jul-2021: Follow up received 29-JUL-2021.  Historical Conditions of Covid-19 updated with onset dates. Allergy to red dye added. Patient height and weight added. Action Taken updated.
sore neck; second dose not administered for more than 35 days; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (sore neck) and PRODUCT DOSE OMISSION ISSUE (second dose not administered for more than 35 days) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Aspirin) and Drug allergy (antihistamines). Concomitant products included METOPROLOL for an unknown indication.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced NECK PAIN (sore neck) and PRODUCT DOSE OMISSION ISSUE (second dose not administered for more than 35 days). At the time of the report, NECK PAIN (sore neck) and PRODUCT DOSE OMISSION ISSUE (second dose not administered for more than 35 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient called in and stated that he got the 1st shot of the Moderna vaccine back in March at a Convention center. His neck was sore for about a couple days after, it resolved a few days after. He was not sure if this was due to the vaccine or if he hurt himself. That was why he opted not to take the scheduled second shot.patient did not took anything for the sore neck as it went away eventually. No treatment drugs are not provided by reporter.   Reporter did not allow further contact
first time in years, I couldn't breath for three days; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via agency through social media on 30-Nov-2020 .  This case involves patient of unknown demographic who experienced first time in years, couldn't breath for three days (dyspnoea) , while the patient received vaccine Influenza vaccine.  The patient's medical history, past medical treatment(s), concomitant therapy, vaccination(s) and family history were not provided.  On an unknown date of 2019 (reported as last year), the patient received suspect Influenza Vaccine produced by unknown manufacturer (lot number and expiry date not reported) at an unknown dose via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date of 2019, (latency: unknown) after starting the suspect vaccine therapy, the patient got one vaccination and first time experienced couldn't breath for three days (dyspnoea) and this event resolved on an unknown date .Since never the patient felt again.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  There will be no information available on batch number for this case.
Pfizer-BioNTechCOVID-19 Vaccine EUA Sore Throat, fatigue, soreness at ejection site and low grade fever
Person who administered took three separate vials that were almost empty and put the needle in and took to the bottom of whatever there was in each vial out and gave him the vaccine; Vitamin D was 25, a bit low; This is a spontaneous report from a contactable nurse. A 60-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL8982) via unknown route of administration on 27Jan2021 at single dose in left arm for COVID-19 immunization at hospital. Medical history included high cholesterol and blood pressure high both are ongoing. Concomitant medication included amlodipine at 5 mg for blood pressure high, atorvastatin at 20 mg for high cholesterol. The patient previously took first dose (at 60-year-old age) of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 08Jan2021 for COVID-19 immunization. It was stated, "So my husband went to get his second dose of Pfizer COVID-19 Vaccine today and the person who administered it took three separate vials that were almost empty and put the needle in and took to the bottom of whatever there was in each vial out, three different vials and gave him the vaccine. Further stated, "Yes, he had a CBC and I think it went well and the only thing that was his Vitamin D was 25, a bit low in 2021 other than that everything is normal." The outcome of events was unknown.  No follow-up attempts are possible. No further information is expected.
Initial misuse report received from a healthcare professional on 22 October 2013. The cases were received on 21 March 2014. A 2 years old child received 0.5ml dose FLUZONE (No other information was provided regarding the patient). No adverse event was reported. List of documents held by sender: none.
small itchy rash onset 6 hours post vaccine, urticaria worsened over next 24 hours, torso and extremities, improved with zyrtec, resolved day 5.  No other symptoms, no dyspnea, cough, no fever or chills, no arthralgia
He is so very weak; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (He is so very weak) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Lung transplant (Double lung transplant done 12 years ago).   On 30-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Aug-2021, the patient experienced ASTHENIA (He is so very weak). At the time of the report, ASTHENIA (He is so very weak) outcome was unknown.            Concomitant product use was not provided.   Treatment information was not provided.
worsened knee pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (worsened knee pain) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced ARTHRALGIA (worsened knee pain). At the time of the report, ARTHRALGIA (worsened knee pain) outcome was unknown.            No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.
Patient experienced chest tightness  and felt "shaky" starting about 20 minutes after vaccine administration.
Narrative:  Patient got shingrix 6-8-22, within 24-48 hours, patient reports stomach cramps, sweating, temp of 106, chest pain had to call the ambulance was taken to ER. He was told he possibly had an allergic reaction to the Shingrex vaccine. Reports he is doing okay today but he is still sweating.
Allergies and nasal drip in back of throat and sneezing; Allergies and nasal drip in back of throat and sneezing; Allergies and nasal drip in back of throat and sneezing; Eyes watering; This is a spontaneous report from a contactable consumer (patient). A 58-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EJ1686), via an unspecified route of administration on 20Jan2021 at 08:40 at 0.3 mL, single on arm left for covid-19 immunisation. Medical history included high blood pressure diagnosed for a while.  Historical vaccine included flu shot for immunization and experienced allergies. Concomitant medication included hydrochlorothiazide/lisinopril and ascorbic acid/ betacarotene/ biotin/ calcium/ chromium/ colecalciferol/ copper/ folic acid/ iodine/ iron/ lycopene/ magnesium/ manganese/ nicotinamide/ pantothenic acid/ phosphorus/ phytomenadione/ potassium/ pyridoxine hydrochloride/ retinol/ riboflavin/ selenium/ vitamin b1 nos/ vitamin b12 nos/ vitamin e nos/ xantofyl/ zinc (CENTRUM SILVER). Patient had the first Pfizer vaccine on Wednesday, 20Jan2021 at about 8:40AM, yesterday (22Jan2021) she started with allergies and nasal drip in back of throat, eyes watering and sneezing around 10 AM. Stated that this was normal for her to have these allergies this time of the year. Caller reports Temperature of 99.8, "not feverish", no nausea. Caller wanted to know if she was contagious because of the vaccine, if it was possible the vaccine triggered her allergies. States she was just wanting to know if she was able to go to work tomorrow. Caller said "the first time i got the flu shot, it triggered my allergies real bad". Patient was treated symptoms with diphenhydramine hydrochloride (BENADRYL) and stated it got better with the diphenhydramine hydrochloride. Outcome of the events was resolving.
pt recv vax & devel local soreness 1-1 & 1/2 days p/vax;2-3 days p/receiving flu pt broke out in hives;pt has recovered;
33 WM   Received smallpox on 13 February 2003 (Revaccinee?) and Anthrax #2 on 03 March 03.  Client presented to the Emergency Room with 2-3 day history of non-productive cough on 03/05/03. Denied chest pain, nausea, vomiting or diarrhea. Had been seen previous day for dehydration. Physical exam reports RLL decreased breath sounds; RML rales ascultated; CTA; LLL CTA. His SaO2 was 95%. He received two liters of intravenous fluid, dismissed and  referred to cardiology.  His dyspnea worsened overnight.  The repeat CXR was suggestive of CHF.  He was given 40 mg Lasix and improved. ECG had sinus tachycardia (heart rate of 115 bpm). He was never admitted to in-patient status.
Td given at primary MD's office, no record given., patient had no knowledge of Td given at primary MD - Public Health reviewed patient recollection of last Td given patient was unable to recall - so Tdap was given. Primary MD office notified - unable to contact patient for follow up -
This spontaneous report was received from a Registered nurse regarding a 12 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 28-JUL-2017, the patient was vaccinated with improperly stored dose of GARDASIL 9 lot# N004798 with expiration date: 31-OCT-2019 (dosing details and route of administration was not reported) for prophylaxis (product storage error). No adverse effects were reported. The storage temperature was 47 degrees Fahrenheit to 77 degrees Fahrenheit (49F) and time frame was 14 hours. There was no previous temperature excursion. Digital data logger was involved. No product quality complaint was involved. This is one of the several reports from the same reporter.; Sender's Comments: US-009507513-1804USA005153:
Immunization certified technician opened vial of pediatric Pfizer dose (5-11 y) and set aside to be drawn up for an adult Pfizer booster dose instead of adult Pfizer vial. Patient was inadvertently given 0.3ml of undiluted pediatric Pfizer dose (equivalent to approximately 42mcg versus 30mcg patient should have received). CDC was contacted and was told to report to VAERS.
Muscle aches, rash, severe tiredness, aching and flu like symptoms for 3 weeks.
28 y/o service member (SM) was in his usual state of excellent health prior to Nov 2010. Looking back, SM recalls developing symptoms of hyperglycemia sometime around November/Dec 2010. He experienced symptoms of polyuria, polydipsia, leg cramps, fatigue, polyphagia, and weight loss of approximately 40-pound. These symptoms had gradually increased leading him to seek evaluation with civilian providers in Jan 2011. At that time, his glucose level was in the 600s and he was diagnosed with diabetes. Initially, Metformin and Glipizide were initiated, but his glucose levels continued to be in the 400s. He was evaluated by Endocrinology and changed to an intensive insulin regimen including daily LANTUS with pre-meal HUMULOG as well as supplementation for hyperglycemia. He is currently pending a change to continuous insulin infusion. He is not sure if he has been tested for any diabetes-related antibodies or C-peptide. Since diagnosis, SM has been followed through a local civilian Endocrinologist, with some follow-up through military medical providers. SM received anthrax vaccine and FLUMIST in Oct 2010 and Smallpox and Yellow Fever vaccines in July 2010, with multiple vaccines received in June. He denies any unusual or prolonged reactions within the first 1-2 weeks following vaccine receipt. SM does not recall any viral-type symptoms just prior to or on the days of vaccine receipt. SM does not recall a history of infection or symptoms of cough, fever, sinus symptoms, congestion or diarrhea prior to his diagnosis of T1DM. Denies a previous history of elevated glucose or blood pressure levels or history of hypertension. He has no family Hx of T1DM or T2DM.
immed p/vax devel local erythema & spotted areas of erythema over entire body-on & off; DPH given;
My arm was sore for the first 3 days which was not unusual.  The pain completely resolved. Now 8 days later I woke up with a sore arm that is warm to touch and some swelling. I also have a rash and redness on the arm where I recieved the vaccine
Grandma seizure last 30 seconds then she came too and started throwing up. Little blood in stool. Now 7 hrs. later she has a headache and is nauseous with occasional stomach cramps and diarrhea. Kept at home didn't seem to need hospital.
The next day after my vaccination I felt fatigued, and feverish and just decided to take a bed rest and this went on for the next 3 succeeding weeks until it subside on its own.
24 hours after shot chills and fever started. 36 hours after shot swelling of eyes, face, lips started. 48 hours after shot eyes were swollen shut, red to the face and still had chills, fever, headache. At this time on September 26th at approximately 11pm  went to our local hospital emergency room. After seeing doctor determined I had a reaction to the shot. They prescribed Prednisone 10mg and sent home. On September 29th in the am all symptoms were gone.
Information has been received from a nurse practitioner concerning a 19 year old female who was between her second and third vaccination with GARDASIL, 0.5ml injection. Concomitant therapy included hormonal contraceptives (unspecified). On approximately 14-AUG-2007 the patient's pap smear was positive for high risk. The patient's pap smear was positive for high risk persisted. Additional information has been requested.
Breakthrough COVID Case: Symptoms: bad headache, 101 fever, aching muscles, severe sore throat. Within 48 hours, I started taking Paxlovid. Within 48 hours of taking Paxlovid, decrease in all symptoms and all symptoms gone after 72 hours of starting to take Paxlovid.
Neck pain; Headache; Chills; Fever; Hardness on bicep; Pain at injection; Hot to touch; A knot on arm; Could not raise arm above head; Minimal pain; Minimal swelling; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Minimal pain), SWELLING (Minimal swelling), VACCINATION SITE MASS (A knot on arm), JOINT RANGE OF MOTION DECREASED (Could not raise arm above head) and NECK PAIN (Neck pain) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes.    On 18-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN (Minimal pain) and SWELLING (Minimal swelling). On 27-Feb-2021, the patient experienced VACCINATION SITE MASS (A knot on arm), JOINT RANGE OF MOTION DECREASED (Could not raise arm above head), VACCINATION SITE WARMTH (Hot to touch) and VACCINATION SITE PAIN (Pain at injection). On 02-Mar-2021, the patient experienced INDURATION (Hardness on bicep). On an unknown date, the patient experienced NECK PAIN (Neck pain), HEADACHE (Headache), CHILLS (Chills) and PYREXIA (Fever). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, PAIN (Minimal pain), SWELLING (Minimal swelling), VACCINATION SITE MASS (A knot on arm), JOINT RANGE OF MOTION DECREASED (Could not raise arm above head), NECK PAIN (Neck pain), VACCINATION SITE PAIN (Pain at injection), HEADACHE (Headache), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown and VACCINATION SITE WARMTH (Hot to touch) and INDURATION (Hardness on bicep) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medication use of diabetes med  was reported Treatment information also includes, ice.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Contact information updated
Nausea, pre-syncopal followed by syncopal episode. Experienced grogginess after episode that continues on day two.